Nasdaq Moves to Delist Nvni Group After MVLS Compliance Failure; Company Appeals
NVNI sits 40% above its 52-week low of $0.769.
Summary
Nasdaq issued a delisting determination to Nvni Group after the company failed to meet the $35 million MVLS requirement. Nvni has appealed and will present a compliance plan based on stockholders' equity, staying the suspension for now.
Key Events · Legal and Risk Events · NVNI
-
Nasdaq Delisting Determination Received
On July 28, 2026, Nasdaq staff determined Nvni did not regain compliance with the $35 million MVLS requirement by the July 27 deadline, triggering a delisting process.
-
Hearing Request Stays Suspension
Nvni timely requested a hearing before the Nasdaq Hearings Panel, automatically staying the trading suspension and Form 25-NSE filing pending the panel's decision.
-
Compliance Plan Under Equity Standard
At the hearing, Nvni will present a plan to meet the $2.5 million stockholders' equity requirement under Rule 5550(b)(1), citing a capital restructuring including conversion of earn-out and convertible obligations into equity.
-
Trading Suspension Otherwise August 6
Absent the hearing request, Nasdaq would have suspended trading at the open on August 6, 2026, and filed to remove the securities from listing.
Analysis · NVNI · Technology
Nvni Group received a Nasdaq delisting determination letter after failing to regain the $35 million minimum market value of listed securities by the July 27 deadline. The company has requested a hearing, which automatically stays the suspension. At the hearing, Nvni plans to argue for continued listing under the stockholders' equity standard, citing a capital restructuring that it expects will push pro forma equity above the $2.5 million threshold. The outcome is binary: if the panel rejects the plan, the stock will be suspended and moved to the OTC market, severely impairing liquidity and investor access.
At the time of this filing, NVNI was trading at $1.08 on NASDAQ in the Technology sector, with a market capitalization of approximately $12.6M. The 52-week trading range was $0.77 to $16.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.